Development of A Predictive Radiomics Model for Lymph Node Metastases in Pre-surgical CT-based Stage IA Non-Small Cell Lung Cancer
Lung cancer has been identified as the leading cause of cancer-related deaths worldwide and one of the most common malignancies in China [1]. More and more non-small cell lung cancer (NSCLC) patients have been observed in the screening projects for detection of early stage lung cancer with the use of low dose computed tomography (CT) [2]. Accurate imaging for evaluation of the Lymph Node Metastases (LNM) could affect the treatment of these patients [3]. Many imaging modalities such as CT, Magnetic Resonance Imaging (MRI), Positron Emission Tomography-CT (PET-CT), as well as other diagnostic techniques like ultrasound-guided biopsy, and thoracoscopy have been applied to evaluate LNM in the NSCLC patients [4,5].
Source: Lung Cancer - Category: Cancer & Oncology Authors: Mengdi Cong, Hui Feng, Jia-Liang Ren, Qian Xu, Lining Cong, Zhenzhou Hou, Yuan-yuan Wang, Gaofeng Shi Source Type: research
More News: Cancer | Cancer & Oncology | China Health | CT Scan | Lung Cancer | Men | MRI Scan | Non-Small Cell Lung Cancer | PET Scan | Ultrasound